Skip to main content
. 2017 Aug 30;7:9989. doi: 10.1038/s41598-017-10577-7

Figure 7.

Figure 7

Effect of XWL-1-48 on growth of HCC in vivo. (A,B) Athymic nude mice bearing HepG2 tumor xenografts were orally administered every other day vehicle control (sterile normal saline), XWL-1-48 (2 and 4 mg/kg), and VP16 (23 mg/kg) for 15 days. Relative Tumor Volume and body weight were measured every other day. (C) The picture showed the tumor size of HepG2 xenograft at the end of the experiment. (D) Tumor tissues were weighed and further inhibitory rate of tumor weight were calculated. Data are mean ± SD of the tumor weight for each group of 7 experimental animals. (E,F) Protein expression in xenografts was determined after 15-day of XWL-1-48 or VP16 treatment. Tumors were harvested 2 h after the last dose. γ-H2AX, p-p53, p53; p-Akt, Akt, p-Mdm2 and total Mdm2 were analyzed by immunoblot analysis.